UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 134

Sortiert nach

1044 TELAPREVIR IN HEPATITIS C GENOTYPE-1-INFECTED PATIENTS WITH PRIOR NON-RESPONSE, VIRAL BREAKTHROUGH OR RELAPSE TO PEGINTERFERON- ALFA-2A/B AND RIBAVIRIN THERAPY: SVR RESULTS OF THE PROVE3 STUDY

Journal of hepatology, 2009, Vol.50, p.S379-S379

2009

Volltextzugriff (PDF)

1184 CHARACTERIZATION OF HCV VARIANTS IN GENOTYPE 1 TREATMENT-NAIVE PATIENTS ADMINISTERED THE COMBINATION OF TVR AND VX-222 IN DUAL ARMS OF ZENITH STUDY

Journal of hepatology, 2012-04, Vol.56, p.S468-S469

2012

Volltextzugriff (PDF)

13 COMBINATION OF THE NS5A INHIBITOR, GS-5885, THE NS3 PROTEASE INHIBITOR, GS-9451, AND PEGYLATED INTERFERON PLUS RIBAVIRIN IN TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION

Journal of hepatology, 2013-04, Vol.58, p.S6-S6

2013

Volltextzugriff (PDF)

1403 SIGNIFICANT IMPROVEMENT OF COMPLETE EVR IN HCVAC PHASE II CLINICAL TRIAL WHEN ADDING TG4040 THERAPEUTIC VACCINE TO PEGIFNα2A AND RIBAVIRIN

Journal of hepatology, 2012-04, Vol.56, p.S552-S552

2012

Volltextzugriff (PDF)

62 PHASE II HCVac STUDY OF TG4040 IMMUNOTHERAPEUTIC IN COMBINATION WITH PEGIFNa2a AND RIBAVIRIN IN GENOTYPE 1 CHC TREATMENT NAÏVE PATIENTS: SVR24 FINAL RESULTS

Journal of hepatology, 2013-04, Vol.58, p.S28-S28

2013

Volltextzugriff (PDF)

818 HCV-TARGET: A LONGITUDINAL, OBSERVATIONAL STUDY OF NORTH AMERICAN PATIENTS WITH CHRONIC HEPATITIS C (HCV) TREATED WITH BOCEPREVIR OR TELAPREVIR

Journal of hepatology, 2013-04, Vol.58, p.S335-S335

2013

Volltextzugriff (PDF)

Aging Liver and Hepatitis

Clinics in geriatric medicine, 2007-11, Vol.23 (4), p.889-903

2007

Volltextzugriff (PDF)

All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.115-126

2017

Volltextzugriff (PDF)

Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection

PloS one, 2013-06, Vol.8 (6), p.e64992-e64992

2013

Volltextzugriff (PDF)

Analysis of Urinary Calculi Using Photon Induced X-Ray Fluorescence (XRF)

The Journal of urology, 1987-07, Vol.138 (1), p.225-225

1987

Volltextzugriff (PDF)

Antiviral therapy of chronic viral hepatitis

The American journal of gastroenterology, 1990, Vol.85 (6), p.650-654

1990

Volltextzugriff (PDF)

Antiviral therapy of chronic viral hepatitis. ACG Committee on FDA-Related Matters

The American journal of gastroenterology, 1990-06, Vol.85 (6), p.650-654

1990

Volltextzugriff (PDF)

Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C

Hepatology (Baltimore, Md.), 2005-03, Vol.41 (3), p.617-625

2005

Volltextzugriff (PDF)

Benign extrinsic œsophageal dysphagia: case reports

South African medical journal, 1985-02, Vol.67 (6), p.219-221

1985

Volltextzugriff (PDF)

Bi-weekly administration of capecitabine + oxaliplatin (XELOX-2) in first line treatment of advanced colorectal cancer (ACRC): Preliminary results

European journal of cancer supplements, 2008-10, Vol.6 (14), p.120-120

2008

Volltextzugriff (PDF)

Biliary‐Venous Fistula Complicating Transjugular Intrahepatic Portosystemic Shunt Presenting With Recurrent Bacteremia, Jaundice, Anemia and Fever

American journal of transplantation, 2003-12, Vol.3 (12), p.1604-1607

2003

Volltextzugriff (PDF)

CD81 binding regions of hepatitis C virus remain conserved after liver transplantation

The Brazilian journal of infectious diseases, 2004-04, Vol.8 (2), p.126-132

2004

Volltextzugriff (PDF)

Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2010-04, Vol.31 (7), p.719-734

2010

Volltextzugriff (PDF)

Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C

The American journal of gastroenterology, 2001, Vol.96 (8), p.2468-2472

2001

Volltextzugriff (PDF)

Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C

The American journal of gastroenterology, 2001-08, Vol.96 (8), p.2468-2472

2001

Volltextzugriff (PDF)

Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and Hepatitis B Virus Genotype

Clinical gastroenterology and hepatology, 2015, Vol.13 (1), p.183-192

2015

Volltextzugriff (PDF)

Children with Chronic Hepatitis B in the United States and Canada

The Journal of pediatrics, 2015-12, Vol.167 (6), p.1287-1294.e2

2015

Volltextzugriff (PDF)

Chronic fatigue syndrome: Lack Of association with hepatitis C virus infection

Journal of medical virology, 1991-06, Vol.34 (2), p.119-121

1991

Volltextzugriff (PDF)

Chronic hepatitis B

Postgraduate medicine, 1995-07, Vol.98 (1), p.99-106

Di Bisceglie, Adrian M

1995

Volltextzugriff (PDF)

Chronic hepatitis B: Hope for decreasing its impact

Postgraduate medicine, 1995-07, Vol.98 (1), p.99-106

Di Bisceglie, Adrian M.

1995

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Aktive Filter

KollektionIEEE Xplore Digital Library

Zeitschrift / SerieGastroenterology

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(133)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

1044 TELAPREVIR IN HEPATITIS C GENOTYPE-1-INFECTED PATIENTS WITH PRIOR NON-RESPONSE, VIRAL BREAKTHROUGH OR RELAPSE TO PEGINTERFERON- ALFA-2A/B AND RIBAVIRIN THERAPY: SVR RESULTS OF THE PROVE3 STUDY

1184 CHARACTERIZATION OF HCV VARIANTS IN GENOTYPE 1 TREATMENT-NAIVE PATIENTS ADMINISTERED THE COMBINATION OF TVR AND VX-222 IN DUAL ARMS OF ZENITH STUDY

13 COMBINATION OF THE NS5A INHIBITOR, GS-5885, THE NS3 PROTEASE INHIBITOR, GS-9451, AND PEGYLATED INTERFERON PLUS RIBAVIRIN IN TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION

1403 SIGNIFICANT IMPROVEMENT OF COMPLETE EVR IN HCVAC PHASE II CLINICAL TRIAL WHEN ADDING TG4040 THERAPEUTIC VACCINE TO PEGIFNα2A AND RIBAVIRIN

62 PHASE II HCVac STUDY OF TG4040 IMMUNOTHERAPEUTIC IN COMBINATION WITH PEGIFNa2a AND RIBAVIRIN IN GENOTYPE 1 CHC TREATMENT NAÏVE PATIENTS: SVR24 FINAL RESULTS

818 HCV-TARGET: A LONGITUDINAL, OBSERVATIONAL STUDY OF NORTH AMERICAN PATIENTS WITH CHRONIC HEPATITIS C (HCV) TREATED WITH BOCEPREVIR OR TELAPREVIR

Aging Liver and Hepatitis

All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database

Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection

Analysis of Urinary Calculi Using Photon Induced X-Ray Fluorescence (XRF)

Antiviral therapy of chronic viral hepatitis

Antiviral therapy of chronic viral hepatitis. ACG Committee on FDA-Related Matters

Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C

Benign extrinsic œsophageal dysphagia: case reports

Bi-weekly administration of capecitabine + oxaliplatin (XELOX-2) in first line treatment of advanced colorectal cancer (ACRC): Preliminary results

Biliary‐Venous Fistula Complicating Transjugular Intrahepatic Portosystemic Shunt Presenting With Recurrent Bacteremia, Jaundice, Anemia and Fever

CD81 binding regions of hepatitis C virus remain conserved after liver transplantation

Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis C

Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C

Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C

Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and Hepatitis B Virus Genotype

Children with Chronic Hepatitis B in the United States and Canada

Chronic fatigue syndrome: Lack Of association with hepatitis C virus infection

Chronic hepatitis B

Chronic hepatitis B: Hope for decreasing its impact

Aktive Filter

Suchergebnisse filtern